ArticleThe journal of allergy and clinical immunology. Global2025
Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1).
Alex Wonnaparhown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.